Alkermes (ALKS) EBIT Growth (1y) (2011 - 2026)
Alkermes (ALKS) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 25.63% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.30% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -14.89% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -46.83% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 719.49% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 23.29% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -450.06% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -20.32% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -235.28% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 273.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -450.06% |
| Dec 31, 2025 | -64.29% |
| Sep 30, 2025 | -14.96% |
| Jun 30, 2025 | -15.38% |
| Mar 31, 2025 | -68.15% |
| Dec 31, 2024 | 153.03% |
| Sep 30, 2024 | 17.45% |
| Jun 30, 2024 | -60.93% |
| Mar 31, 2024 | 494.72% |
| Dec 31, 2023 | -365.41% |
| Sep 30, 2023 | 247.09% |
| Jun 30, 2023 | 916.29% |
| Mar 31, 2023 | 58.73% |
| Dec 31, 2022 | -10.68% |
| Sep 30, 2022 | -208.46% |
| Jun 30, 2022 | -879.39% |
| Mar 31, 2022 | -61.79% |
| Dec 31, 2021 | 521.15% |
| Sep 30, 2021 | -84.30% |
| Jun 30, 2021 | 113.13% |